| (Values in U.S. Thousands) | Dec, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
| Sales | 12,290 | 24,380 | 24,750 | 49,190 | 47,390 |
| Sales Growth | -49.59% | -1.49% | -49.68% | +3.80% | +11.04% |
| Net Income | 53,380 | -53,950 | -37,660 | -32,900 | -24,830 |
| Net Income Growth | +198.94% | -43.26% | -14.47% | -32.50% | -13.74% |
Elutia Inc (ELUT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Elutia Inc. develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them. Elutia Inc., formerly known as Aziyo Biologics Inc., is based in SILVER SPRING, Md.
Fiscal Year End Date: 12/31